TAmiRNA GmbH

Founded

2013

Staff

5

Organization type

RDM biotech/pharma

Region

Vienna

TAmiRNA seeks to identify and characterize small non-coding RNA molecules referred to as “microRNAs”, which contribute to the process of aging or the development of age-related diseases. Ultimately, TAmiRNA uses this knowhow to develop novel medical applications of microRNAs as diagnostic tests or therapeutic drugs to enable personalized treatment of disease.

R&D:Novel, minimal-invasive in-vitro diagnostic tests are developed in the following areas: musculoskeletal, cardiovascular and metabolic diseases.

Services:TAmiRNA offers services for RNA biomarker discovery, validation and commercialization.